"A local and national leader in eye care services, ranked in the top 10 ophthalmology programs in the U.S. for more than 20 years."

During the past decade, USC Roski Eye Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "USC Roski Eye Institute" #1 collaborator was "ELZA Institute" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Pierre Fabre Medicament" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "USC Roski Eye Institute" are "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials), "Brain Neoplasms" (1 trials), "Brain Neoplasms, Primary" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Keratoconus" (1 trials). Many other conditions were trialed in "USC Roski Eye Institute" in a lesser frequency.

Most popular intervention types in "USC Roski Eye Institute" are "Drug" (4 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Binimetinib" (2 trials), "Sham Procedure" (2 trials), "4mg CLS-TA Suprachoriodal Injection" (1 trials), "5-Fluorouracil" (1 trials) and "Cetuximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "USC Roski Eye Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "USC Roski Eye Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in USC Roski Eye Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in USC Roski Eye Institute, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".